Opioid prescribing : where you live matters by National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.
JULY 2017
The amount of opioids prescribed in the US peaked in 2010 and 
then decreased each year through 2015. However, prescribing 
remains high and vary widely from county to county. Healthcare 
providers began using opioids in the late 1990s to treat chronic 
pain (not related to cancer), such as arthritis and back pain. As 
this continued, more opioid prescriptions were written, for more 
days per prescription, in higher doses. Taking opioids for longer 
periods of time or in higher doses increases the risk of addiction, 
overdose, and death. In 2015, six times more opioids per 
resident were dispensed in the highest-prescribing counties than 
in the lowest-prescribing counties. County-level characteristics, 
such as rural versus urban, income level, and demographics, 
only explained about a third of the differences. This suggests 
that people receive different care depending on where they live.  
Healthcare providers have an important role in offering safer and 
more effective pain treatment.
Healthcare providers can:
 ■ Follow the CDC Guideline for Prescribing Opioids for Chronic 
Pain, which includes recommendations such as:
`` Use opioids only when benefits are likely to outweigh risks.
`` Start with the lowest effective dose of immediate-release 
opioids.  For acute pain, prescribe only the number of days 
that the pain is expected to be severe enough to require 
opioids. 
`` Reassess benefits and risks if considering dose increases. 
 ■ Use state-based prescription drug monitoring programs 
(PDMPs) which help identify patients at risk of addiction  
or overdose.
6x
Providers in the 
highest prescribing 
counties prescribed 
6 times more opioids 
per person than the 
lowest prescribing 
counties in 2015.  
50% 
Half of US counties 
had a decrease 
in the amount of 
opioids (MME*) 
prescribed per 
person from  
2010 to 2015. 
3x
The MME prescribed 
per person in 2015 
was still more than  
3 times as high as  
in 1999.  
Opioid Prescribing
Where you live matters
Want to learn more? www.cdc.gov/vitalsigns/opioids
* MME, morphine milligram equivalents, 
is a way to calculate the total amount 
of opioids, accounting for differences in 
opioid drug type and strength.
Some characteristics of counties with 
higher opioid prescribing:
MME PER PERSON
Despite recent declines, opioid prescribing 
is still high and inconsistent across the US.
Problem:
SOURCE: CDC Vital Signs, July 20172
`` Small cities or large towns
`` Higher percent of white residents
``More dentists and primary  
care physicians
``More people who are  
uninsured or unemployed
``More people who have diabetes, 
arthritis, or disability
Higher opioid prescribing puts patients at risk for addiction and overdose. The wide variation among counties suggests a lack 
of consistency among providers when prescribing opioids. The 2016 CDC Guideline for Prescribing Opioids for Chronic 
Pain offers recommendations that may help to improve prescribing practices and ensure all patients receive safer, more 
effective pain treatment.
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The amount of opioids prescribed per person was three 
times higher in 2015 than in 1999.
SOURCES: Automation of Reports and Consolidated Orders System (ARCOS) of the Drug 






The amount of opioids 
prescribed per person varied 
widely among counties in 2015. 
Some characteristics of counties with 
higher opioid prescribing:
Problem:  













Problem:  High prescribing























Promising actions for safer opioid prescribing
3SOURCE: CDC Vital Signs, July 2017
In 2015, the amount of opioids 
prescribed was enough for every 
American to be medicated around 
the clock for 3 weeks.
Even at low doses, 
taking an opioid for 
more than 3 months 
increases the risk of 
addiction by 15 times.
 A dose of 50 MME or 
more per day doubles the 
risk of opioid overdose 
death, compared to 20 
MME or less per day. At 
90 MME or more, the risk 
increases 10 times.
Use opioids only when benefits are likely 
to outweigh risks. Options other than 
opioids include:
 ■ Pain medicines like acetaminophen, 
ibuprofen, and naproxen
 ■ Physical therapy and exercise
 ■ Cognitive behavioral therapy 
For acute pain, prescriptions should 
only be for the expected duration 
of pain severe enough to need 
opioids. Three days or less is often 
enough; more than seven days is 
rarely needed.
Use the lowest effective dose of 
immediate-release opioids when 
starting, and reassess benefits 
and risks when considering dose 
increases. 
For more recommendations when considering opioids for chronic pain outside of end-of-life care, see The CDC Guideline 
for Prescribing Opioids for Chronic Pain. The Guideline can also be used to inform health systems, states, and insurers 
to ensure appropriate prescribing and improve care for all people.
www.cdc.gov/drugoverdose/prescribing/guideline.html
Average days supply per prescription increased 
from 2006 to 2015.
Average daily MME per prescription declined both 
nationwide and in most counties, but it is still too high. 
Therapies that don’t 
involve opioids may 
work better and have 
fewer risks and side 
effects.
If continuing opioids, 
ask whether benefits 
continue to outweigh 
risks. If not, use other 
treatments and taper 
opioids gradually.
Avoid a daily dose 
of 90 MME or more. 
If already taking 
high doses, offer 
the opportunity to 
gradually taper to 
safer doses.
(640 MME per person, which equals 5 mg of 
hydrocodone every 4 hours)
What Can Be Done?
The Federal Government is
 ■ Educating healthcare providers and the public about 
pain management, addiction, and opioid overdose 
and providing guidance on safe and effective pain 
management.
 ■ Equipping states with resources to implement and 
evaluate safe prescribing practices.
 ■ Improving access to addiction treatment and 
recovery services.
 ■ Increasing access to overdose-reversing drugs, such 
as naloxone.
 ■ Tracking opioid-related trends to better understand 
and respond to the epidemic.
 ■ Supporting cutting-edge research about pain 
management and addiction.
States can 
 ■ Maximize prescription drug monitoring programs 
(PDMPs) by using near real-time data reporting, 
integrating with electronic health records, and 
promoting routine provider use.
 ■ Implement and evaluate programs to improve 
prescribing practices.
 ■ Use data to identify and address high-risk 
prescribing. 
 ■ Enhance the use of prescribing guidelines based on 
the best available science.
 ■ Increase access to medication-assisted treatment 
for addiction and naloxone for opioid overdose.
Health insurers can
 ■ Refer to the Guideline in setting up prescription 
claims review programs to identify and address 
improper prescribing and use of opioids.
 ■ Increase coverage for other proven treatments to 
reduce pain, such as physical therapy and non-
opioid pain medicines.
 ■ Cover clinicians’ time when they are conducting 
activities that improve quality and safety of pain 
management and addressing addiction. These can 
include patient counseling, coordination of care, 
and checking the patient’s prescription history in 
the PDMP.
 ■ Reduce barriers (such as prior authorization) to use 
of nonopioid pain medications and medication-
assisted treatment for addiction. 
Healthcare providers can:
 ■ Follow the CDC Guideline for Prescribing Opioids 
for Chronic Pain, which includes recommendations 
such as:
`` Use opioids only when benefits are likely to 
outweigh risks.
`` Start with the lowest effective dose of immediate-
release opioids.  For acute pain, prescribe only the 
number of days that the pain is expected to be 
severe enough to require opioids.
`` Reassess benefits and risks if considering dose 
increases. 
 ■ Use state-based PDMPs which help identify 
patients at risk of addiction or overdose.
Everyone can 
 ■ Consider non-opioid options for pain management.
 ■ Store prescription opioids in a secure place, out of 
reach of others (including children, family, friends, 
and visitors). 
 ■ Dispose of medications properly as soon as the 
course of treatment is done. For more information, 
visit FDA at: www.fda.gov/Drugs/ResourcesForYou.
 ■ Get help if you’re having trouble controlling your 
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